Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

11. LOANS RECEIVABLE: Schedule of Loans Receivable (Tables)

v3.21.2
11. LOANS RECEIVABLE: Schedule of Loans Receivable (Tables)
12 Months Ended
Dec. 31, 2020
Tables/Schedules  
Schedule of Loans Receivable

 

 

Notes

 

2020

 

2019

Advances to PharmaCo Inc.

 

$

11,084,278

$

4,381,329

Promissory note receivable from PharmaCo Inc.

 

 

32,627,616

 

30,648,517

Promissory note acquired with RTO

5

 

4,231,664

 

-

Accrued interest on promissory note acquired with RTO

5

 

686,288

 

-

Net receivable from sellers of Platinum Vape

6

 

3,046,777

 

-

Settlement of pre-existing relationship in MAG acquisition

6

 

-

 

1,474,551

Total

 

$

51,676,623

$

36,504,397